Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_assertion type Assertion NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_head.
- NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_assertion description "[After stimulation with TLR2 and TLR4 agonists, AVICs express higher levels of pro-inflammatory and pro-osteogenic mediators (bone morphogenetic protein [BMP]-2, runt-related transcription factor 2) and greater osteogenic phenotypic changes (alkaline phosphatase [ALP] activity, calcified nodule formation) than PVICs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_provenance.
- NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_assertion evidence source_evidence_literature NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_provenance.
- NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_assertion SIO_000772 19195606 NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_provenance.
- NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_assertion wasDerivedFrom befree-20140225 NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_provenance.
- NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_assertion wasGeneratedBy ECO_0000203 NP379905.RAo2mc6uGnCG0RVxP0Wo31de260N9I9KFeSWqGcnlxVDA130_provenance.